BOARD OF DIRECTORS
Michael Zilbershlag, CEO, Board member
Michael Zilbershlag, CEO and cofounder of Leviticus Cardio. Michael is the former CEO and founder of GenesisOS,
a developer of advanced DRM solutions for embedded systems. Michael held various R&D positions at ECI Telecom (NASDAQ: ECIL), Orckit Communications (NASDAQ: ORCT), Sandlinks Inc. and Broadlight Inc.; Entrepreneur with vast R&D experience in communications and medical devices as well as vast experience in system engineering; Michael earned a B.Sc. in Electrical Engineering and MBA.
Michael@leviticus-cardio.com
Pr. Ivan Netuka, Professor of Cardiac Surgery and Chairman of the Department of Cardiovascular Surgery, IKEM, Prague
Professor of Cardiac Surgery and Chairman of the Department of Cardiovascular Surgery at IKEM, Prague. Dr. Netuka has authored and published over 100 peer-reviewed book chapters and manuscripts focusing predominantly on all aspects of advanced heart failure, cardiac transplantation, surgical treatment modalities and alternatives to transplantation with a special focus on mechanical circulatory assistance. In 2014 he has been elected as a member of the Executive Committee of EUROMACS/EACTS. Additionally, he serves as a reviewer for numerous international professional cardiology and cardiothoracic surgery journals. Among his international longer-term professional assignments, Norway, Germany, India and most recently in 2016 Brigham and Women’s Hospital and Harvard Medical School
Jiri Maly, MD, PhD
Dr. Maly serves as Deputy Director at IKEM Prague and Vice Chairman of Department of Cardiovascular Surgery. Dr. Maly has been appointed as Associate Professor of Surgery at Charles University, Prague. He specialized predominantly on advanced heart failure, cardiac transplantation, with special focus on acute and chronic mechanical circulatory support. Another strong interest is aortic surgery and cathether based treatment of structural heart disease. Dr. Maly has authored and published over 50 peer-reviewed scientific articles. His special focus is apllication of basic hemodynamic principles for predicting the effects of device based treatments for acute heart failure.
Steve Rhodes, Board member
Steve shares the positions of Chairman and CEO of The Trendlines Group with Todd and additionally serves as chairman of the Mofet Innovation Accelerator. Steve earned an MBA from the University of Chicago and a bachelor's degree from Harvard University. He is a certified public accountant in the state of Illinois. Formerly , Steve served in several position at Chicago branch of Bank Leumi, and At Bank Leumi in Israel. In 1988, Steve Rhodes joins SRD Medical, Israeli medical device startup developing a real time
depth of anesthesia monitor; serves as CFO and, later, VP marketing.
|
